G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.85
-0.85 (-2.25%)
Mar 10, 2026, 9:37 AM CST
-30.30%
Market Cap 2.40B
Revenue (ttm) 311.78M
Net Income (ttm) 143.10M
Shares Out 63.72M
EPS (ttm) 2.24
PE Ratio 16.82
Forward PE n/a
Dividend 0.70 (2.04%)
Ex-Dividend Date Jul 29, 2025
Volume 21,000
Average Volume 58,707
Open 38.50
Previous Close 37.70
Day's Range 36.85 - 38.50
52-Week Range 33.00 - 56.60
Beta -0.91
RSI 45.64
Earnings Date Mar 19, 2026

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products in Taiwan. It offers Hepanamin capsules; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 39
Stock Exchange Taipei Exchange
Ticker Symbol 4911
Full Company Profile

Financial Performance

In 2024, G&E Herbal Biotechnology's revenue was 249.03 million, an increase of 37.25% compared to the previous year's 181.44 million. Earnings were 102.06 million, an increase of 40.97%.

Financial Statements

News

There is no news available yet.